Somatic mutations in the Krebs cycle enzyme isocitrate dehydrogenase (IDH) have been described in gliomas, acute myeloid leukemia, cholangiocarcinoma, melanoma, colorectal, prostate cancer, and thyroid carcinoma [20]. Here, IDH2 is linked to glioma.